+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BERLDRG BERLDRG

Beryl Drugs Share Price

₹26.40 +1.86 (7.58%)
Near 52W High of ₹27.60

09 Oct, 2026 4:01 PM (IST)

Beryl Drugs live price: ₹26.40. It opened at ₹26 vs previous close ₹25; intraday high/low: ₹27/₹24. The 50 & 200 DMA stand at ₹23.80/₹22.90.

Beryl Drugs Performance

  • Today's Low
  • ₹24
  • Today's High
  • ₹27
  • 52 Week Low
  • ₹16
  • 52 Week High
  • ₹28
  • Open Price₹26
  • Previous Close₹25
  • Volume3,498
  • 50 DMA₹23.80
  • 100 DMA₹23.20
  • 200 DMA₹22.90

Beryl Drugs Chart

Investment Returns

  • Over 1 Month + 9.45%
  • Over 3 Month + 8.11%
  • Over 6 Month + 8.51%
  • Over 1 Year + 12.34%

Smart Investing Starts Here Start SIP with Beryl Drugs for Steady Growth!

Invest Now

Beryl Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 21.4
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 13
  • P/B Ratio
  • 1.3
  • Average True Range
  • 2.4
  • EPS
  • 1.2
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.6
  • RSI
  • 61.13
  • MFI
  • 73.29

Latest Stock News Updates

Beryl Drugs Ltd - 524606 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS, 2018 FOR THE QUARTER ENDED 30.09.2026

Beryl Drugs Ltd - 524606 - Compliance-57 (5) : intimation after the end of quarter

NON- APPLICABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30.09.2026

Beryl Drugs Ltd - 524606 - Closure of Trading Window

CLOSURE OF TRADING WINDOW

Beryl Drugs Financials

Beryl Drugs Technicals

EMA & SMA

Current Price
₹26.40
+ 1.86 (7.58%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹24.60
  • 50 Day
  • ₹23.80
  • 100 Day
  • ₹23.20
  • 200 Day
  • ₹22.90

Resistance and Support

25.93 Pivot Speed
  • R3 29.90
  • R2 28.40
  • R1 27.40
  • S1 24.80
  • S2 23.30
  • S3 22.30

Beryl Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-09-02 A.G.M.
2026-08-11 Quarterly Results
2026-06-16 Others Inter alia, to consider and approve change in registered office of the company within local limits of the same city.
2026-05-28 Audited Results
2026-04-01 Notice of EGM & Others Inter-alia, to consider 1. Appointment of Mr. Shailendra Pathak as the Whole Time Director. 2. Appointment of Abhay Bhandari & Associates. 3. Authorize Directors of the Com. 4.Other business matters.

Beryl Drugs Shareholding Pattern

72.19%
27.82%
0%

Beryl Drugs FAQs

Beryl Drugs share price is ₹26 As on 11 October, 2026 | 22:14

The Market Cap of Beryl Drugs is ₹13.4 Cr As on 11 October, 2026 | 22:14

The P/E ratio of Beryl Drugs is 21.4 As on 11 October, 2026 | 22:14

The PB ratio of Beryl Drugs is 1.3 As on 11 October, 2026 | 22:14

The 52 week High & Low of Beryl Drugs is ₹27.6/₹15.9 respectively As on 11 October, 2026 | 22:14

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23